Corona Remedies’ IPO is scheduled to debut on the stock exchanges today, December 15, following strong investor demand during ...

The IPO of Corona Remedies opens for subscription today, giving investors a chance to participate in one of the pharma sector’s fast-growing companies. Backed by ChrysCapital, the issue has already ...

The initial public offering of Corona Remedies saw strong investor interest, being subscribed more than 137x from 8-10.

According to Investorgain, Corona Remedies' unlisted shares are trading at a grey market premium (GMP) of Rs 290. Considering ...

Once the allotment is finalised, investors who applied for Corona Remedies IPO can check their status on the official ...

Ahead of the Dalal Street debut, the grey market premium is indicating a robust listing gain of around 32 per cent, according ...

Arun Kejriwal, Founder of Kejriwal Research and Investment Services, believes that the issue is expected to get benefit of ...

Corona Remedies Share Price, IPO Listing, GMP Live Updates: Corona Remedies is all set to hit the secondary market, after the ...

Corona Remedies launched its IPO today to raise more than Rs 655 crore entirely through an offer for sale (OFS) of shares ...

The two mainboard IPOs currently open for subscription are witnessing markedly different investor interest on Day 2. While ...

Up to 35 per cent of the IPO is reserved for retail investors, 50 per cent for qualified institutional buyers (QIBs), and 15 ...

Corona Remedies IPO GMP Day 1, Subscription Status Live Updates: The initial public offering of Corona Remedies kicked off today, marking the first day of bidding for the Rs 655 crore issue. Investors ...